Results 91 to 100 of about 8,263 (168)

Neoadjuvant tislelizumab (anti-PD-1 antibody) plus chemotherapy in patients with advanced epithelial ovarian cancer: the exploratory NAIVE trial. [PDF]

open access: yesSignal Transduct Target Ther
Zhang Z   +14 more
europepmc   +1 more source

Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica. [PDF]

open access: yesACR Open Rheumatol
Tanaka S   +14 more
europepmc   +1 more source

Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis. [PDF]

open access: yesIntensive Care Med Exp
Lima PDA   +7 more
europepmc   +1 more source

The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study. [PDF]

open access: yesEJNMMI Radiopharm Chem
Gómez-Sánchez M   +5 more
europepmc   +1 more source

Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells. [PDF]

open access: yesCell Rep Med
Tsai AK   +26 more
europepmc   +1 more source

Towards prediction of CML Treatment Outcomes with Machine Learning and CyTOF Data [PDF]

open access: yes
Predicting responses to therapy for patients with Chronic Myeloid Leukemia (CML) is crucial for optimizing treatment strategies. This study utilizes machine learning models with mass cytometry (CyTOF) data from samples taken before treatment, at 3 hours ...
Bergenheim, Mathilde Blom
core  

Single-cell profiling reveals CCL5Hi GZMAHi effector memory CD8 T cell association to oligoarticular JIA. [PDF]

open access: yesRheumatology (Oxford)
Lopez-Corbeto M   +9 more
europepmc   +1 more source

High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLC. [PDF]

open access: yesFront Immunol
Kim KH   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy